You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 3, 2026

Formulation information for generic ingredient: orlistat

✉ Email this page to a colleague

« Back to Dashboard

ORLISTAT

CASRN: 96829-58-2

Manufacturing Methods

…

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing